XML 22 R9.htm IDEA: XBRL DOCUMENT
v3.21.2

Certain Balance Sheet Accounts | 6 Months Ended
--- | ---
Jun. 30, 2021
Certain Balance Sheet Accounts |
Certain Balance Sheet Accounts | Note 4—Certain Balance Sheet Accounts Accounts Receivable, net Accounts receivable, net consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2021 |  | 2020
​ | ​ | (In thousands)
Trade receivables, net | ​ | $ | 31,418 | ​ | $ | 3,771
Sublease and other receivables | ​ |  | 420 | ​ |  | 70
Total accounts receivables, net | ​ | $ | 31,838 | ​ | $ | 3,841
​ Trade receivables are net of product return and chargeback allowances of $1.9 million and $1.2 million as of June 30, 2021 and December 31, 2020, respectively. Inventory Inventory consists of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2021 |  | 2020
​ | ​ | (In thousands)
Raw materials |  | $ | 361 |  | $ | 109
Work-in-progress | ​ |  | 230 | ​ |  | 462
Finished goods | ​ |  | 387 | ​ |  | 784
Total inventory |  | $ | 978 |  | $ | 1,355
​ Property and Equipment, Net Property and equipment, net consists of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | December 31,
​ | ​ | 2021 | ​ | 2020
​ | ​ | (In thousands)
Finance leases | ​ | $ | 5,690 | ​ | $ | 5,690
Laboratory equipment | ​ |  | 2,998 | ​ |  | 2,898
Computer equipment | ​ |  | 985 | ​ |  | 985
Office equipment and furniture | ​ |  | 625 | ​ |  | 625
Total cost | ​ |  | 10,298 | ​ |  | 10,198
Less accumulated depreciation and amortization | ​ |  | (8,391) | ​ |  | (7,647)
Total property and equipment, net | ​ | $ | 1,907 | ​ | $ | 2,551
​ For the three months ended June 30, 2021 and 2020, depreciation and amortization expenses were $0.4 million for each of the two periods. For the six months ended June 30, 2021 and 2020, depreciation and amortization expenses were $0.7 million and $0.8 million, respectively. Accrued Expenses Accrued expenses consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | December 31,
​ | ​ | 2021 | ​ | 2020
​ | ​ | (In thousands)
Sales rebates, fees and discounts | ​ | $ | 7,572 | ​ | $ | 3,326
Contract research and development | ​ | ​ | 5,576 | ​ |  | 7,952
Consulting and professional fees | ​ |  | 4,770 | ​ | ​ | 5,393
Interest payable | ​ |  | 5,173 | ​ |  | 5,205
Employee compensation | ​ |  | 7,872 | ​ |  | 3,948
Clinical trials | ​ |  | 1,874 | ​ |  | 2,121
Other accrued expenses | ​ |  | 484 | ​ |  | 810
Total accrued expenses | ​ | $ | 33,321 | ​ | $ | 28,755
​

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration